In 2023, Italy led R&D expenditure in human health activities, with a notable value of 525.14 million USD PPP. Italy showed a 5.3% year-on-year growth, while Israel and Taiwan also demonstrated robust increases at 4.89% and 3.21%, respectively. Remarkable growth is observed in Romania, with a 93.52% rise, although starting from a much lower base. Portugal and Poland indicated steady upward trends with 22.06% and 10.47% growth, respectively. Countries like Lithuania and Hungary also reflected significant growth, indicating emerging focus and investments in health R&D in these regions.
Future trends to watch include the increasing investment patterns in less traditionally dominant nations, likely driven by expanding needs in technological advancement in healthcare and global health crises. This diversification of R&D investment could lead to more innovative solutions spanning across various regions.
Top countries in Business Enterprise R&D Expenditure in Human Health Activities by Country
| # | 10 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 525.14 | 2023 | +5.76% | +5.3% | View data |
| 2 | 2 Israel | 374.61 | 2023 | +4.46% | +4.89% | View data |
| 3 | 3 Taiwan | 331.56 | 2023 | +3.59% | +3.21% | View data |
| 4 | 4 Spain | 139.85 | 2023 | +4.18% | +1.75% | View data |
| 5 | 5 Portugal | 57.5 | 2023 | +16.24% | +22.06% | View data |
| 6 | 6 Poland | 57.22 | 2023 | +8.68% | +10.47% | View data |
| 7 | 7 South Korea | 42.13 | 2023 | +5.5% | +19.74% | View data |
| 8 | 8 New Zealand | 40.54 | 2023 | +7.23% | View data | |
| 9 | 9 Finland | 25.1 | 2021 | +57.72% | View data | |
| 10 | 10 Hungary | 16.06 | 2023 | +4.06% | +7.26% | View data |
